Evidence map›Paper›PMID 25928882›Full record

ArticleGenes and immunity

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection.

J Ampuero, J A del Campo, L Rojas, R J García-Lozano, M Buti, R Solá, X Forns, R Moreno-Otero, R Andrade, M Diago and 11 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.Frontiers in cell and developmental biology · 2020
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 1 country.

J AmpueroUnit for the Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, Sevilla, Spain.
J A del CampoUnit for the Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, Sevilla, Spain.
L RojasUnit for the Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, Sevilla, Spain.
R J García-LozanoImmunology Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
M ButiHepatology Unit, Hospital Vall d'Hebron and CIBERehd, Barcelona, Spain.
R SoláDigestive Department, Hospital del Mar, Barcelona, Spain.
X FornsLiver Unit and IDIBAPS, Hospital Clinic and CIBERehd, Barcelona, Spain.
R Moreno-OteroDigestive Department, Hospital de la Princesa, Madrid, Spain.
R AndradeGastroenterology Department, Hospital Virgen de la Victoria and CIBERehd, Málaga, Spain.
M DiagoDigestive Department, Hospital General de Valencia, Valencia, Spain.
J SalmerónDigestive Department, Hospital Universitario San Cecilio and CIBERehd, Granada, Spain.
L RodrigoGastroenterology Department, Hospital Central de Asturias, Oviedo, Spain.
J A PonsGastroenterology Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
J M NavarroGastroenterology Department, Hospital Costa del Sol, Marbella, Spain.
J L CallejaLiver Unit, Hospital Puerta de Hierro, Madrid, Spain.
J García-SamaniegoHepatology Unit, Hospital Carlos III & CIBERehd, Madrid, Spain.
M García-ValdecasasUnit for the Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, Sevilla, Spain.
Á RojasUnit for the Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, Sevilla, Spain.
R MillánUnit for the Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, Sevilla, Spain.
M F González-EscribanoImmunology Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
M Romero-GómezUnit for the Clinical Management of Digestive Diseases and CIBERehd, Valme University Hospital, Sevilla, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESHospital Universitario de Valme · ESHospital Universitario Virgen del Rocío · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital Costa del Sol · ESHospital Del Mar · ESHospital General Universitario De Valencia · ESHospital Universitario Central de Asturias · ESHospital Universitario de La Princesa · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Virgen de la Arrixaca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Host-viral genetic interaction has a key role in hepatitis C infection (HCV) and maybe in the viral selection. In a preliminary GWAS analysis, we identified BTN3A2 rs9104 to be associated with HCV genotype 1. Therefore, our aim was to determine the influence of BTN family on the selection of HCV genotype. We performed a fine-mapping analysis of BTN gene region in a cohort of chronic HCV infection (N=841), validating significant results in another independent chronic HCV infection cohort (N=637), according to selection of viral genotype. BTN3A2 rs9104, BTN3A2 rs733528, BTN2A1 rs6929846, BTN2A1 rs7763910 and BTN3A3 rs13220495 were associated with viral genotype selection. Interestingly, BTN3A2 rs9104 GG genotype was closely related to genotype 1 infection (80.7% (394/488) compared with genotype 3 infection (53.5% (23/43); P=0.0001) in patients harboring IL28B-CT/TT genotype, although this effect was not observed in IL28B-CC genotype. Similarly, BTN3A3 rs13220495 CC genotype was linked to genotype 3 infection (100% (32/32)) compared to genotype 1 (87.3% (137/157); P=0.028) in patients harboring IL28B-CC genotype, but did not in IL28B-CT/TT genotype. Genetic variants in the butyrophilin family genes may alter susceptibility to infection, selecting HCV genotype and influencing disease progression. BTN3A2 rs9104 was strongly associated with genotype 1 infection and the haplotype BTN3A3 rs13220495 CC+IL28B genotype CC was universal in patients with hepatitis C genotype 3a.

Indexed as

Polymorphism, Single NucleotideSelection, GeneticButyrophilinsGenotypeHepacivirusHepatitis CHost-Pathogen InteractionsHumansMembrane GlycoproteinsMultigene FamilyButyrophilinsMembrane Glycoproteins

Identifiers

PMID25928882
OpenAlexW1964596103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.